BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Rhythm 

The John Hancock Tower, 54th Floor
200 Clarendon Street
Boston  Massachusetts  02116  U.S.A.
Phone: 617-425-9200 Fax: 617-425-9201


SEARCH JOBS




Industry
Biotechnology






 Company News
Boston's Rhythm Files For $86 Million IPO 8/27/2014 2:52:16 PM
Rhythm Presents Clinical Data That RM-493 Increases Energy Expenditure In Obesity Study 6/23/2014 6:50:50 AM
Rhythm Presents Positive GI Motility Results For Relamorelin (RM-131) In Phase 2 Chronic Constipation Study 5/6/2014 9:49:25 AM
Rhythm Presents Positive Phase 2 Study Results For Ghrelin Prokinetic Relamorelin (RM-131) In Diabetic Gastroparesis 5/6/2014 9:48:22 AM
Rhythm To Present At The Cowen and Company 34th Annual Health Care Conference 3/3/2014 6:43:33 AM
Rhythm Initiates Clinical Trial of RM-493 for Obesity Caused by Genetic Variant 9/24/2013 10:06:19 AM
Rhythm Awarded $1.35 Million From The Michael J. Fox Foundation to Advance Clinical Development of RM-131 for Refractory Constipation in Parkinson's Disease 9/10/2013 9:24:47 AM
Rhythm Lands $11 Million Tranche to Advance Its Treatment of GI Disorders 7/31/2013 8:35:17 AM
Rhythm Announces Study Demonstrating High Prevalence of Diabetic Gastroparesis Symptoms in the U.S. 5/20/2013 1:50:18 PM
Rhythm Announces Phase 1b Results for Ghrelin Prokinetic RM-131 for Gastroparesis in Patients with Type 1 Diabetes 5/20/2013 10:44:34 AM
123